Citations

Mayo Clinic

Showing 10 of 108522 citations.

Transitive inference in a clinical childhood sample with a focus on autism spectrum disorder
Kao, Tina , Michaelcheck, Charlotte, Terrace, H. S. , Jensen, Greg , Jensen, Greg , Ferrera, Vincent P.

Autism Research | September 3, 2024 | Volume: 17 | Issue: 11 | Pages: 2355-2369

10.1002/aur.3225 | PMID 39223913 Get It

AbstractTransitive inference (TI) has a long history in the study of human development. There have, however, few pediatric studies that report clinical diagnoses have tested trial‐and‐error TI learning, in which participants infer item relations, rather than evaluate them explicitly from verbal descriptions. Children aged 8–10 underwent a battery of clinical assessments and received a range of diagnoses, potentially including autism spectrum disorder (ASD), attention‐deficit hyperactive disorder (ADHD), anxiety disorders (AD), specific learning disorders (SLD), and/or communication disorders (CD). Participants also performed a trial‐and‐error learning task that tested for TI. Response accuracy and reaction time were assessed using a statistical model that controlled for diagnostic comorbidity at the group level. Participants in all diagnostic categories showed evidence of TI. However, a model comparison analysis suggested that those diagnosed with ASD succeeded in a qualitatively different way, responding more slowly to each choice and improving faster across trials than their non‐ASD counterparts. Additionally, TI performance was not associated with IQ. Overall, our data suggest that superficially similar performance levels between ASD and non‐ASD participants may have resulted from a difference in the speed‐accuracy tradeoff made by each group. Our work provides a preliminary profile of the impact of various clinical diagnoses on TI performance in young children. Of these, an ASD diagnosis resulted in the largest difference in task strategy.
Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
Idalsoaga, Francisco , Díaz, Luis Antonio , Chahuán, Javier , Halawi, Houssam , Arrese, Marco , Arrese, Marco , Díaz, Luis A , Chahuan, Javier , Ayares, Gustavo , Cabrera, Daniel , Monrroy, Hugo , Arab, Juan Pablo

Alimentary Pharmacology & Therapeutics | September 3, 2024 | Volume: 60 | Issue: 8 | Pages: 1141-1142

10.1111/apt.18246 | PMID 39223757 Get It

LINKED CONTENTThis article is linked to Idalsoaga et al papers. To view these articles, visithttps://doi.org/10.1111/apt.18193andhttps://doi.org/10.1111/apt.18220
Optimal Deep  Barcodes for Fast Image Retrieval
Khosrowshahli, Rasa , Kheiri, Farnaz , Bidgoli, Azam Asilian , Makrehchi, Masoud , Rahnamayan, Shahryar , Tizhoosh, Hamid R.

No container title available | September 3, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4818178/v1 Get It

Abstract Binary encoding of features has proven to be a versatile tool for optimizing data processing and memory efficiency in various machine learning applications. This includes deep barcoding of images for retrieval of similar cases among millions of indexed images. Despite the recent advancement in barcode generation methods, converting hyperdimensional feature vectors (e.g., deep features) to compact and discriminative binary barcodes is still an urgent necessity and widely an unresolved problem. MinMax barcoding of features is one of the efficient binarization methods, where the accuracy of the generated barcodes is inherently dependent on the feature order due to its computation process. In this paper, we propose a combinatorial evolutionary framework for optimizing barcodes. The primary goal is to determine an optimal permutation of extracted deep features, leading to more accurate barcodes. The performance of the proposed model has been assessed in downstream image retrieval tasks using a variety of datasets. This evaluation includes medical images from The Cancer Genome Atlas (TCGA), a comprehensive publicly available dataset, as well as images from a COVID-19 dataset. In addition, the model's performance was tested on diverse non-medical image collections, such as CIFAR-10 and Fashion-MNIST. Our findings demonstrate that optimizing barcodes significantly enhances retrieval accuracy across a wide range of applications, highlighting the applicability and potential of barcodes in various domains.
Somatic, emotional, and gastrointestinal symptom severity are increased among children and adolescents with COVID‐19
Berken, Jonathan A. , Keeley, Kaitlyn, Katz, Ben Z. , Fortunato, John E. , Saps, Miguel , Wechsler, Joshua B , Saps, Miguel , Singer, Wolfgang , Jhaveri, Ravi R.

Neurogastroenterology & Motility | September 3, 2024 | Volume: 36 | Issue: 11 | Pages: No page available

10.1111/nmo.14909 | PMID 39223749 Get It

AbstractBackgroundPost‐infectious disorders of gut‐brain interaction (PI‐DGBI) have significant impact on children and adolescents. The effect of COVID‐19 on PI‐DGBI‐associated symptoms in this population, however, is unknown.MethodsWe performed electronic medical record searches to identify patients 8–17 years old with a SARS‐CoV2 PCR test at Lurie Children's Hospital between November 2020 and March 2021 (cohort 1) and April–October 2021 (cohort 2). Questionnaires were administered to assess symptoms prior to and 3 months following the test. This included the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS), questionnaire of pediatric gastrointestinal symptoms—Rome IV, Nausea Profile (NP), dyspepsia symptom survey (DSS), nausea severity profile (NSP), and Pediatric Quality of Life Inventory (PedsQL). We grouped patients based on the presence of symptoms prior to COVID‐19 test or the test result.ResultsOne hundred and ninety‐six parent(s) or guardian(s) in cohort 1 and 274 in cohort 2 completed surveys and self‐reported their child's COVID‐19 result. Cohort 1 had increased PEESS and DSS scores, lower PedsQL scores, and increased frequency of abdominal pain disorders among patients with symptoms prior to COVID‐19 testing. Both cohorts had increased NP and NSP scores among patients with symptoms prior to COVID‐19 testing that was highest among patients with a positive COVID‐19 test. Abdominal pain and diarrhea prior to COVID‐19 testing predicted higher NP scores.ConclusionsAmong symptomatic COVID‐19 tested children, we found increased severity of nausea‐associated somatic, emotional, and gastrointestinal symptoms in the 3 months following the test that was most increased among patients with a positive COVID‐19 test.
Does the Maximum Initial Beam Energy for Proton Therapy Have to Be 230 MeV?
Perales, Álvaro , Furutani, Keith M. , Furutani, Keith M , Beltran, Chris

Quantum Beam Science | September 3, 2024 | Volume: 8 | Issue: 3 | Pages: 23

10.3390/qubs8030023 Get It

Proton therapy is increasingly widespread and requires an accelerator to provide the high energy protons. Most often, the accelerators used for proton therapy are cyclotrons and the maximum initial beam energy (MIBE) is about 230 MeV or more to be able to achieve a range of approximately 30 cm in water. We ask whether such a high energy is necessary for adequate dosimetry for pathologies to be treated with proton beams. Eight patients of different clinical sites (brain, prostate, and head and neck cancers) were selected to conduct this study. We analyzed the tumor dose coverage and homogeneity, as well as healthy tissue protection for MIBE values of 120, 160, 180, 200 and 230 MeV. For each patient, a proton plan was developed using the particular MIBE and then using multifield optimization (MFO). In this way, 34 plans in total were generated to fulfill the unique clinical goals. This study found that MIBE of 120 MeV for brain tumors; 160 MeV for head and neck cancer; and remarkably, for prostate cancer, only 160 MeV for one patient case and 180 MeV for the remainder satisfied the clinical goals (words: 187 < approx. 200 words or less)
Pathological features of connective tissue disease‐associated interstitial lung disease in transbronchial cryobiopsies
Churg, Andrew , Ravaglia, Claudia , Vašáková, Martina , Manjarres, D.C. Gomez, Tazelaar, Henry D. , Wright, Joanne L, Ravaglia, Claudia , Vaszar, Laszlo T. , Tazelaar, Henry, Poletti, Venerino , Matěj, Radoslav , Hornychová, Helena , Stewart, Brian D. , Patel, Divya C. , Duarte, Ernesto Martinez , Mehta, Hiren J. , Tazelaar, Henry D. , Wright, Joanne L

Histopathology | September 3, 2024 | Volume: 86 | Issue: 2 | Pages: 260-267

10.1111/his.15311 | PMID 39223069 Get It

AimTransbronchial cryobiopsies are increasingly used for the diagnosis of interstitial lung disease (ILD), but there is a lack of published information on the features of specific ILD in cryobiopsies. Here we attempt to provide pathological guidelines for separating usual interstitial pneumonia (UIP) of idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis (FHP) and connective tissue disease‐associated ILD (CTD–ILD) in cryobiopsies.MethodsWe examined 120 cryobiopsies from patients with multidisciplinary discussion (MDD)‐established CTD–ILD and compared them to a prior series of 121 biopsies from patients with MDD‐established IPF or FHP.ResultsA non‐specific interstitial pneumonia (NSIP) pattern alone was seen in 36 of 120 (30%) CTD–ILD, three of 83 (3.6%) FHP and two of 38 (5.2%) IPF cases, statistically favouring a diagnosis of CTD–ILD. The combination of NSIP + OP was present in 29 of 120 (24%) CTD–ILD, two of 83 (2.4%) FHP and none of 38 (0%) IPF cases, favouring a diagnosis of CTD–ILD. A UIP pattern, defined as fibroblast foci plus any of patchy old fibrosis/fibrosis with architectural distortion/honeycombing, was identified in 28 of 120 (23%) CTD–ILD, 45 of 83 (54%) FHP and 27 of 38 (71%) IPF cases and supported a diagnosis of FHP or IPF. The number of lymphoid aggregates/mm2 and fibroblast foci/mm2 was not different in IPF, CTD–ILD or FHP cases with a UIP pattern. Interstitial giant cells supported a diagnosis of FHP or CTD–ILD over IPF, but were infrequent.ConclusionsIn the correct clinical/radiological context the pathological findings of NSIP, and particularly NSIP plus OP, favour a diagnosis of CTD–ILD in a cryobiopsy, but CTD–ILD with a UIP pattern, FHP with a UIP pattern and IPF generally cannot be distinguished.
Commentary on Milky Urine in a Patient with Poorly Controlled Type II Diabetes
Hata, D. Jane , Hoyne, Jonathan , Hoyne, Jonathan B

Clinical Chemistry | September 3, 2024 | Volume: 70 | Issue: 9 | Pages: 1103-1103

10.1093/clinchem/hvae105 | PMID 39222935 Get It

Reproducibility of cardiac computed tomography classifications of hypoattenuated thickening and peridevice leak following left atrial appendage closure
Kramer, Anders , Russo, Gerardo Lo , Alarouri, Hasan S. , Collins, Jeremy D. , Jensen, Jesper Møller , Nielsen‐Kudsk, Jens Erik , Alkhouli, Mohamad , Korsholm, Kasper , Lo Russo, Gerardo , Møller Jensen, Jesper , Alkhouli, Mohamad , Collins, Jeremy , Korsholm, Kasper , Kramer, Anders Dahl

European Heart Journal - Cardiovascular Imaging | September 2, 2024 | Volume: 26 | Issue: 1 | Pages: 62-71

10.1093/ehjci/jeae236 | PMID 39225186 Get It

Abstract Aims To assess the reproducibility of interpreting hypoattenuated thickening (HAT) and peridevice leak (PDL) using cardiac computed tomography (CT) imaging following Watchman FLX left atrial appendage closure (LAAC). Methods and results In this multicentre retrospective reproducibility study, 100 anonymized post-LAAC cardiac CT scans were evaluated within the same cardiac phase by an experienced and a novice rater blinded to prior evaluations. All scans were evaluated twice by each rater, assessing overall HAT and PDL categories as well as specific associated findings based on suggested algorithms for post-LAAC interpretation. Inter- and intra-rater agreement and reliability were evaluated using absolute agreement, Cohen’s kappa, and Kendall’s tau for categorical variables, and mean difference, Bland–Altman plots, limits of agreement (lower and upper), and intra-class correlation coefficients (ICCs) for continuous variables. Within overall categories of both HAT and PDL, substantial agreement (kappa ≥0.61) and reliability (Kendall’s tau-b ≥ 0.75) were observed. Specifically, identifying high-grade HAT (kappa ≥0.78) and distal patency (kappa ≥0.85) displayed the highest agreement within HAT and PDL interpretation. Meanwhile, measuring the height of the proximal screw hub cove represented the least reliable HAT assessment among both inter- and intra-rater comparisons (ICC &lt; 0.75), while suspected leak mechanism represented the least reproducible PDL measure. Conclusion Despite only minimal training of one rater, overall high levels of inter- and intra-rater agreement and reliability were observed across the chosen algorithms for interpretation of HAT and PDL following Watchman FLX LAAC. The prognostic implications of the included variables are to be explored in future trials and registries.
A Systemic Review of Mycobacterium nebraskense Case Reports up to October 2023, Featuring Our Unique Case Study
Rajani, Aayushi J. , Roach, Dawn , Raval, Darshankumar Manubhai, Amin, Juhi , Chitale, Rohit , Durvasula, Ravindra, Oring, Justin , Raval, Darshankumar, Kempaiah, Prakash, Rajani, Aayushi J , Kempaiah, Prakasha

The International Journal of Mycobacteriology | September 2, 2024 | Volume: 12 | Issue: 4 | Pages: 443-447

10.4103/ijmy.ijmy_167_23 | PMID 38149541 Get It

Background: Mycobacterium nebraskense is a rare, slow growing nontuberculous mycobacterium species with limited documented cases. This systematic review aims to comprehensively analyze the clinical characteristics, presentation, and management of M. nebraskense infections by analyzing the available literature, including a newly reported case that we present in this article. Methods: A comprehensive search was conducted using PubMed and Google Scholar to identify relevant cases up to October 2023. Only seven reported cases were found, highlighting the scarcity of information on this pathogen. Results: Our analysis revealed several key findings. First, gender disparities were observed, with females being more susceptible to M. nebraskense infections. Additionally, a significant portion of patients presented with asymptomatic infections. Most affected individuals were over the age of 60, emphasizing potential age-related susceptibility. Comorbidity profiles varied widely among cases, and patients with preexisting lung comorbidities were at an increased risk of infection. The decision to treat or observe depended on clinical presentation, with even immunosuppressed individuals not always requiring treatment. Regarding treatment, we proposed an empirical approach with amikacin, clarithromycin, or rifabutin, considering the reported resistance to doxycycline and minocycline. Combination therapy was commonly employed to minimize resistance development, consistent with mycobacterial infection management. Conclusion: This study underscores the need for further research to validate these findings and enhance our understanding of M. nebraskense infections. As limited data are available, this review aims to provide valuable insights into a rare and emerging pathogen to guide clinical practice and future research endeavors.